Biofil Chemicals Share Price | Biofil Chemicals Stock Screener
BIOFILCHEM
Pharmaceuticals
Share Price NSE
₹31.56
▼
-0.32 (-1.00%)
Share Price BSE
₹31.70
▼
-0.43 (-1.34%)
As of May 20, 2026, the Biofil Chemicals share price (NSE: BIOFILCHEM) is ₹31.56 on NSE and ₹31.70 on BSE, down 1.00% from the previous close, with shares trading between ₹31.26 and ₹32.00, and a 52-week range of ₹25.79–₹46.34.
Check BIOFILCHEM 52-week performance for the annual price range and momentum.
Use the Biofil Chemicals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Biofil Chemicals Market Cap
₹53.12 Cr.
BIOFILCHEM P/E Ratio (TTM)
19.32
Biofil Chemicals P/B Ratio
2.51
EPS (TTM)
₹0.34
Dividend Yield
-
Debt to Equity
0.02
BIOFILCHEM 52 Week High
₹46.34
Biofil Chemicals 52 Week Low
₹25.79
Operating Margin
3.00%
Profit Margin
9.38%
BIOFILCHEM Revenue (TTM)
₹32.00
EBITDA
₹4.00
Net Income
₹3.00
Total Assets
₹51.00
Total Equity
₹19.00
Biofil Chemicals Share Price Chart
Screen Biofil Chemicals share price with an interactive chart. Analyse BIOFILCHEM price trends and volatility across different timeframes.
Biofil Chemicals Company Profile - Fundamental Screener
Screen Biofil Chemicals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for BIOFILCHEM shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE829A01014
Biofil Chemicals Balance Sheet Screener
Screen BIOFILCHEM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 51 | 47 | 31 | 19 | 33 | 42 | 24 | 24 | 22 | 24 |
| Current Assets | 43 | 38 | 22 | 9 | 24 | 32 | 14 | 15 | 13 | 15 |
| Fixed Assets | 8 | 9 | 9 | 9 | 10 | 10 | 10 | 9 | 9 | 9 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 19 | 18 | 17 | 17 | 16 | 15 | 14 | 13 | 13 | 11 |
| Share Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves & Surplus | 3 | 2 | 1 | 1 | 0 | -1 | -3 | -3 | -4 | -5 |
Biofil Chemicals Income Statement Screener - Profit & Revenue Analysis
Screen Biofil Chemicals income statement and profit fundamentals.
Analyze BIOFILCHEM quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Biofil Chemicals share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 32 | 34 | 41 | 30 | 23 | 37 | 30 | 23 | 13 | 14 | 14 | 6 |
| Expenses | 29 | 33 | 39 | 29 | 21 | 34 | 28 | 22 | 11 | 11 | 12 | 5 |
| EBITDA | 4 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 3 | 1 | 1 |
| Operating Profit % | 3.00% | 3.00% | 2.00% | 4.00% | 6.00% | 4.00% | 6.00% | 4.00% | 8.00% | 19.00% | 7.00% | 13.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 3 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 2 | 1 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
| Net Profit | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
| EPS | 1.70 | 0.34 | 0.44 | 0.34 | 0.44 | 0.77 | 0.74 | 0.30 | 0.29 | 1.10 | 0.48 | 0.36 |
Biofil Chemicals Cash Flow Screener - Liquidity Fundamentals
Screen BIOFILCHEM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -2 | 2 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | -1 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | -1 | -1 | 0 | 0 | 0 | 0 |
| Net Cash Flow | -2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Biofil Chemicals Shareholding Pattern Screener
See Biofil Chemicals shareholding pattern with promoter, FII, and DII holdings.
Check Biofil Chemicals promoter holding and ownership changes for BIOFILCHEM on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 46.79% | 46.82% | 46.82% | 46.79% | 46.79% | 46.82% | 46.82% | 46.82% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% | 0.00% |
| DII Holding | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 38.40% | 38.31% | 38.18% | 38.23% | 38.27% | 38.03% | 37.27% | 38.02% |
| Other Holding | 14.73% | 14.79% | 14.92% | 14.89% | 14.86% | 15.04% | 15.83% | 15.08% |
| Shareholder Count | 25,356 | 25,914 | 25,685 | 25,196 | 24,825 | 26,581 | 25,480 | 26,422 |
Biofil Chemicals Share Dividend Screener - Share Yield Analysis
Check Biofil Chemicals dividend history with payout and yield data.
View Biofil Chemicals dividend details including ex-dates and amounts for BIOFILCHEM stock.
Biofil Chemicals Stock Index Membership
See which indices include Biofil Chemicals stock.
Check BIOFILCHEM index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Biofil Chemicals Market Events Screener - Corporate Actions
Get Biofil Chemicals corporate actions including splits, bonuses, and buybacks.
Check Biofil Chemicals stock events that may affect BIOFILCHEM share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -3.98% | ||
| Annual General Meeting | NA | 24.86% | ||
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | -10.98% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 3.78% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -5.23% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 9.61% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | -3.12% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -8.65% |
Biofil Chemicals Competitors Screener - Peer Comparison
Screen BIOFILCHEM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 450,643 | 40.81 | 54,729 | 9.71% | 10,980 | 64.89 |
| Divis Laboratories | 179,470 | 74.13 | 9,712 | 18.67% | 2,191 | 64.06 |
| Torrent Pharmaceuticals | 149,109 | 65.68 | 11,539 | 6.99% | 1,911 | 58.52 |
| Cipla | 115,682 | 30.09 | 27,712 | -2.46% | 3,783 | 69.78 |
| Dr Reddys Laboratories | 111,567 | 26.16 | 33,593 | -0.44% | 3,998 | 59.87 |
| Lupin | 104,032 | 19.28 | 27,488 | 19.98% | 5,345 | 46.11 |
| Mankind Pharma | 103,325 | 56.36 | 12,744 | 20.90% | 2,007 | 73.37 |
| Zydus Life Science | 101,801 | 19.85 | 23,511 | 18.55% | 4,615 | 69.47 |
| Aurobindo Pharma | 87,806 | 25.16 | 32,346 | 9.43% | 3,484 | 73.83 |
| Laurus Labs | 71,455 | 79.78 | 6,813 | 21.03% | 884 | 80.26 |
Biofil Chemicals Company Announcements - News Screener
Screen BIOFILCHEM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-11 | Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015-Intimation To The Shareholders Holding Shares In Physical Mode For Mandatory Furnishing Of PAN KYC Details Bank Account Details Nomination And Ot | - |
| 2026-04-10 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-04-02 | Intimation Regarding SEBI Circular Dated January 30 2026 - Ease Of Doing Investment - Special Window For Transfer And Dematerialisation Of Physical Securities | - |
| 2026-04-01 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-24 | Closure of Trading Window | - |
| 2026-02-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-13 | Un-Audited Financial Results Of The Company For The Quarter And Nine Month Ended On 31St December 2025 | - |
| 2026-02-13 | Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 13Th February 2026 | - |
| 2026-02-03 | Clarification On Price Movement | - |
| 2026-02-03 | Clarification sought from Biofil Chemicals & Pharmaceuticals Ltd | - |
| 2026-02-03 | Board Meeting Intimation for Meeting Of Board Of The Directors (Serial No. 07/2025-26) Of The Company Scheduled To Be Held On Friday 13Th February 2026 . | - |
| 2026-01-02 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-23 | Closure of Trading Window | - |
| 2025-12-03 | Receipt Of Fine From BSE Limited. | - |
| 2025-11-26 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-13 | Board Meeting Outcome for To Review Consider And Approve The Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2025 Along With Limited Review Report | - |
| 2025-11-13 | To Review Consider And Approve The Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2025 Along With Limited Review Report. | - |
| 2025-11-07 | Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September 2025. | - |